SLN short interest
Silence Therapeutics plc · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 2,538,328 |
|---|---|
| Change vs prior report | 360,273 (+16.5%) |
| Change over six months | +38.5% |
| Days to cover | 3.07 (sector: 3.78) |
| Average daily volume | 827,101 |
| Rank in Healthcare | #622 of 922 by days to cover |
SLN short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 2,538,328 | +16.5% | 3.07 | 827,101 |
| 2026-09-15 | 2,178,055 | -10.6% | 2.53 | 861,199 |
| 2026-08-31 | 2,435,831 | +0.1% | 3.50 | 695,204 |
| 2026-08-14 | 2,432,830 | +32.4% | 1.00 | 2,891,078 |
| 2026-07-31 | 1,837,238 | +16.8% | 3.28 | 560,270 |
| 2026-07-15 | 1,572,687 | -9.2% | 3.15 | 499,806 |
| 2026-06-30 | 1,733,018 | -16.1% | 2.24 | 772,826 |
| 2026-06-15 | 2,066,488 | +0.5% | 8.57 | 241,168 |
| 2026-05-29 | 2,057,236 | +3.6% | 9.14 | 225,140 |
| 2026-05-15 | 1,985,927 | -7.9% | 10.92 | 181,913 |
| 2026-04-30 | 2,156,496 | +3.9% | 5.45 | 395,560 |
| 2026-04-15 | 2,075,273 | +13.3% | 4.65 | 446,721 |
| 2026-03-31 | 1,832,291 | +5.9% | 4.70 | 389,578 |
| 2026-03-13 | 1,730,158 | +11.4% | 5.37 | 322,252 |
| 2026-02-27 | 1,553,269 | +0.2% | 12.57 | 123,574 |
| 2026-02-13 | 1,550,765 | +12.6% | 7.62 | 203,508 |
| 2026-01-30 | 1,376,890 | +3.7% | 5.08 | 270,993 |
| 2026-01-15 | 1,327,897 | +5.4% | 3.75 | 353,831 |
| 2025-12-31 | 1,259,539 | +12.6% | 4.25 | 296,479 |
| 2025-12-15 | 1,118,938 | +6.8% | 3.10 | 360,873 |
| 2025-11-28 | 1,047,426 | +13.6% | 4.12 | 254,304 |
| 2025-11-14 | 922,085 | +65.5% | 4.87 | 189,206 |
| 2025-10-31 | 557,169 | -11.3% | 2.92 | 191,102 |
| 2025-10-15 | 627,952 | -15.5% | 4.42 | 142,066 |
| 2025-09-30 | 743,480 | -8.1% | 11.67 | 63,703 |
import finzdata as yf
yf.Ticker("SLN").short_interest # every report since 2017
yf.Client().short_interest(["SLN"], start="2018-01-01")Healthcare short interest · SLN price history · Who owns SLN · All short interest